-+ 0.00%
-+ 0.00%
-+ 0.00%

Crescent Biopharma announces annual shareholder meeting notice

PUBT·04/21/2026 20:18:28
Listen to the news
Crescent Biopharma announces annual shareholder meeting notice
  • Crescent Biopharma scheduled annual general meeting for June 2, 2026 via virtual webcast.
  • Shareholders to vote on election of Class II directors Jonathan Violin, Ph.D. and Susan Moran, M.D., MSCE.
  • Ballot includes ratification of PricewaterhouseCoopers as independent registered public accounting firm for fiscal 2026.
  • Meeting also features advisory vote on named executive officer compensation.
  • Separate advisory vote set for frequency of future say-on-pay votes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-026282), on April 21, 2026, and is solely responsible for the information contained therein.